Biostar Pharma Stock Price (NASDAQ:BSPM)

Add to My Stocks
$1.95 $0.07 (3.72%) BSPM stock closing price Sep 19, 2018 (Closing)
Prev Close* : $1.88
Market Cap:
$4.96M
Day Low: $1.68
52 Week Low: $1.19
Open: $1.69
Volume: -
Day High: $1.95
52 Week High: $5.97
Dividend:
0.00

Latest Stock Market News

Latest Articles

BSPM Stockcharts

View BSPM PE ratio, PS ratio stocks charts and compare with peers.
BSPM Chart
Note: Compare Biostar Pharma stock price history with the index and industry peers.

Biostar Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Biostar Pharma Returns

ROE
(return on equity)

Biostar Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Biostar Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues2.38M27.12M61.41M52.72M49.31M
Net Income-5.69M-25.11M4.84M--19.99M
Total Operating Expense4.47M34.86M31.58M25.16M51.63M
View Biostar Pharma income statement
balance sheet20162015201420132012
Total Assets42.5M51.36M81.24M67.56M70.47M
Total Liabilities5.62M7.09M8.91M4.79M12.7M
Shareholders Equity36.87M44.26M72.33M62.77M57.77M
View Biostar Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities7.3M5.34M-6.07M2.23M6.3M
Net Cash from (used by) Operating Activities4.91M5.87M3.31M8.9M-3.58M
Increase (Decrease) in Prop Plant And Equipment--0.05M-2.86M-0.98M-0.01M
View Biostar Pharma cash flow statement

Biostar Pharma Stock Message Board

An investor needs to spend $1.95 to buy BSPM stock, as the closing Biostar Pharma stock price is $1.95. Looking at Biostar Pharma market capitalization, which currently stands at $4.96M, we can say that BSPM stock is a Nano Cap stock. Biostar Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy BSPM stock than sell it, then Biostar Pharma stock price goes up. Conversely, if more investors wanted to sell BSPM stock than buy it, there would be greater supply than demand, and the stock price would fall. 137,163 BSPM shares were traded yesterday, and Biostar Pharma stock chart shows that the BSPM stock quote hit a day high of $1.95 and day low of $1.68. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Biostar Pharma dividend per share was 0.00 during the last quarter. Biostar Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.